Therapeutic inhibition of RIP1 improves metabolic dysfunction and inhibits atherosclerosis in mouse models of cardiometabolic diseases
Denuja Karunakaran(The University of Queensland), Katey J. Rayner(University of Ottawa), Joshua W. Kandiah(MACOM (United States)), Michèle Geoffrion(University of Ottawa), Ella deKemp(University of Ottawa), Ana Mompeón(Northwestern University), Richard Lee(Ionis Pharmaceuticals (United States)), Zachary Lister(MACOM (United States)), My Anh Nguyen(University of Ottawa), Hailey Wyatt(Yale University)
Cited by 1
Related Papers
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
|Nature|2010|4k
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
|Nature Immunology|2009|1.5k
MiR-33 Contributes to the Regulation of Cholesterol Homeostasis
|Science|2010|1.3k